SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-195410
Filing Date
2024-08-07
Accepted
2024-08-07 07:14:02
Documents
15
Period of Report
2024-08-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d878134d8k.htm   iXBRL 8-K 26130
2 EX-99.1 d878134dex991.htm EX-99.1 7767
6 GRAPHIC g878134g84g18.jpg GRAPHIC 14175
  Complete submission text file 0001193125-24-195410.txt   177907

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycn-20240807.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20240807_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20240807_pre.xml EX-101.PRE 11710
17 EXTRACTED XBRL INSTANCE DOCUMENT d878134d8k_htm.xml XML 3757
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 241181414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)